J.P. Delord
Impact in
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- PARP inhibition in cancer therapy
- Otorhinolaryngology top 5%
- Head and Neck Cancer Studies
Papers in
- Oncology 32
- Colorectal Cancer Treatments and Studies 10
- Cancer Treatment and Pharmacology 5
- Cancer Immunotherapy and Biomarkers 5
- PARP inhibition in cancer therapy 5
- HER2/EGFR in Cancer Research 4
-
- Lung Cancer Treatments and Mutations 7
- Co-authors
- Karim Fizazi (3 shared papers)O. Rixe (1 shared paper)M. Riofrio (1 shared paper)M. Spielmann (1 shared paper)A. Le Cesne (1 shared paper)Laurent Zelek (1 shared paper)Christine Chevreau (5 shared papers)Antoîne Italiano (7 shared papers)
- Journals
- Annals of Oncology (16 papers)Journal of Clinical Oncology (8 papers)British Journal of Cancer (4 papers)Cancer Research (4 papers)European Journal of Cancer (2 papers)
- Partner nations
- FranceSwitzerlandUnited States
In The Last Decade
J.P. Delord
47 papers receiving 973 citations
Peers
Comparison fields: 5 of 70
- Oncology 706
- Otorhinolaryngology 78
- Cancer Research 162
- Pulmonary and Respiratory Medicine 276
- Immunology 117
Countries citing papers authored by J.P. Delord
This map shows the geographic impact of J.P. Delord's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.P. Delord with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.P. Delord more than expected).
Fields of papers citing papers by J.P. Delord
This network shows the impact of papers produced by J.P. Delord. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.P. Delord. The network helps show where J.P. Delord may publish in the future.
Co-authors
The 25 scholars most cited alongside J.P. Delord, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 122 | |
| 2 | 2010 | 78 | |
| 3 | 2016 | 77 | |
| 4 | 2013 | 53 | |
| 5 | 2017 | 52 | |
| 6 | 2008 | 52 | |
| 7 | 2008 | 42 | |
| 8 | 2018 | 41 | |
| 9 | 2019 | 41 | |
| 10 | 2015 | 36 | |
| 11 | 2000 | 35 | |
| 12 | 2019 | 34 | |
| 13 | 2010 | 33 | |
| 14 | 2015 | 31 | |
| 15 | 2015 | 27 | |
| 16 | 2009 | 22 | |
| 17 | 2000 | 18 | |
| 18 | 2019 | 18 | |
| 19 | 2004 | 17 | |
| 20 | 2011 | 17 |
About J.P. Delord
J.P. Delord is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Pathology and Forensic Medicine and Surgery, having authored 48 papers that have together received 981 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (10 papers), Lung Cancer Treatments and Mutations (7 papers), Cancer Treatment and Pharmacology (5 papers), Melanoma and MAPK Pathways (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Cancer Genomics and Diagnostics (5 papers), PARP inhibition in cancer therapy (5 papers) and HER2/EGFR in Cancer Research (4 papers). The work is most often cited by research in Oncology (706 citations), Otorhinolaryngology (78 citations), Cancer Research (162 citations), Pulmonary and Respiratory Medicine (276 citations) and Immunology (117 citations). J.P. Delord has collaborated with scholars based in France, Switzerland and United States. Frequent co-authors include Karim Fizazi, O. Rixe, M. Riofrio, M. Spielmann, A. Le Cesne, Laurent Zelek, Christine Chevreau, Antoîne Italiano, Bettina Couderc and Christophe Le Tourneau. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, British Journal of Cancer, Cancer Research and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.